Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Zuna

Showing results (1-10 of 50) with videos related to

Pageof 5
Sort By:
Haematologica|October 30, 2025
CML-like biology: BCR::ABL1 and beyondJan Zuna
F1000Research|October 23, 2018
New biological and genetic classification and therapeutically relevant categories in childhood B-cell precursor acute lymphoblastic leukemiaJan Starý, Jan Zuna, Marketa Zaliova
International Journal of Hematology|February 20, 2013
Reappearance of acute lymphoblastic leukemia 34 years after initial diagnosis: a case report and study of the origin of the reappeared blastsFumio Bessho, Nobuyuki Takayama, Eva Fronkova, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 28, 2026
Measurable Residual Disease in Pediatric Acute Leukemia: Application and Interpretation of Current and Emerging MethodologiesLisa Eidenschink Brodersen, Alexandra E Kovach, Jan Zuna
Experimental Hematology|January 25, 2012
The adaptor protein NTAL enhances proximal signaling and potentiates corticosteroid-induced apoptosis in T-ALLKarel Svojgr, Tomas Kalina, Veronika Kanderova, et al.
Genes, Chromosomes & Cancer|May 11, 2016
Slower early response to treatment and distinct expression profile of childhood high hyperdiploid acute lymphoblastic leukaemia with DNA index < 1.16Marketa Zaliova, Lenka Hovorkova, Martina Vaskova, et al.
Immunology Letters|February 3, 2009
Adaptor molecules expression in normal lymphopoiesis and in childhood leukemiaKarel Svojgr, Tatiana Burjanivova, Martina Vaskova, et al.
Plos One|August 6, 2016
Intragenic ERG Deletions Do Not Explain the Biology of ERG-Related Acute Lymphoblastic LeukemiaEliska Potuckova, Jan Zuna, Lenka Hovorkova, et al.
Pediatric Blood & Cancer|December 16, 2010
TEL/AML1-positive patients lacking TEL exon 5 resemble canonical TEL/AML1 casesMarketa Zaliova, Claus Meyer, Gunnar Cario, et al.
Cancer Genetics|November 12, 2015
Long-term remission of therapy-related acute myeloid leukemia with a new t(11;18)(q23;q21.2) translocation and KMT2A-ME2 (MLL-ME2) fusion geneTomáš Szotkowski, Marie Jarošová, Olga Zimmermannová, et al.
Pageof 5

Showing results (1-10 of 50) with videos related to

Sort By:
Pageof 5
Haematologica|October 30, 2025
CML-like biology: BCR::ABL1 and beyondJan Zuna
F1000Research|October 23, 2018
New biological and genetic classification and therapeutically relevant categories in childhood B-cell precursor acute lymphoblastic leukemiaJan Starý, Jan Zuna, Marketa Zaliova
International Journal of Hematology|February 20, 2013
Reappearance of acute lymphoblastic leukemia 34 years after initial diagnosis: a case report and study of the origin of the reappeared blastsFumio Bessho, Nobuyuki Takayama, Eva Fronkova, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 28, 2026
Measurable Residual Disease in Pediatric Acute Leukemia: Application and Interpretation of Current and Emerging MethodologiesLisa Eidenschink Brodersen, Alexandra E Kovach, Jan Zuna
Experimental Hematology|January 25, 2012
The adaptor protein NTAL enhances proximal signaling and potentiates corticosteroid-induced apoptosis in T-ALLKarel Svojgr, Tomas Kalina, Veronika Kanderova, et al.
Genes, Chromosomes & Cancer|May 11, 2016
Slower early response to treatment and distinct expression profile of childhood high hyperdiploid acute lymphoblastic leukaemia with DNA index < 1.16Marketa Zaliova, Lenka Hovorkova, Martina Vaskova, et al.
Immunology Letters|February 3, 2009
Adaptor molecules expression in normal lymphopoiesis and in childhood leukemiaKarel Svojgr, Tatiana Burjanivova, Martina Vaskova, et al.
Plos One|August 6, 2016
Intragenic ERG Deletions Do Not Explain the Biology of ERG-Related Acute Lymphoblastic LeukemiaEliska Potuckova, Jan Zuna, Lenka Hovorkova, et al.
Pediatric Blood & Cancer|December 16, 2010
TEL/AML1-positive patients lacking TEL exon 5 resemble canonical TEL/AML1 casesMarketa Zaliova, Claus Meyer, Gunnar Cario, et al.
Cancer Genetics|November 12, 2015
Long-term remission of therapy-related acute myeloid leukemia with a new t(11;18)(q23;q21.2) translocation and KMT2A-ME2 (MLL-ME2) fusion geneTomáš Szotkowski, Marie Jarošová, Olga Zimmermannová, et al.
Pageof 5